Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Williams-Sonoma reports its next quarterly results on August 26 — days after clearing its August 21 print with a stock now trading at $237.58, up roughly 7.5% over the past month, and holding well above the consensus analyst target of $229.25.
The prior article noted analysts were racing to lift targets into the August 21 print, and the stock has since consolidated those gains. Short sellers have retreated sharply alongside the rally. SI has fallen 14% over the past month to 4.6% of the free float — around 5.5 million shares — and the borrow market is entirely relaxed. Cost to borrow barely registers at 0.50%, and availability is extraordinarily loose at 1,669% — meaning the lending pool holds roughly 17 times more shares than are currently borrowed. There is no meaningful squeeze setup here. Options positioning is modestly more cautious than usual: the put/call ratio nudged up to 1.01 this week, about one standard deviation above its 20-day average of 0.92, but far short of the elevated readings the stock has seen in the past year. The overall positioning picture looks watchful, not alarmed.
The analyst debate has sharpened around valuation rather than direction. Most of the target upgrades from firms including Goldman Sachs (Buy, $261) and RBC Capital (Outperform, $260) came before the August 21 print — and with the stock now trading above the Street's mean target, the consensus has effectively been lapped by the tape. The bull case rests on comp sales momentum, margin execution, and B2B growth providing a revenue stream less exposed to consumer cyclicality. Forward EPS growth ranks in the 90th percentile of WSM's comparable universe. Bears counter that the valuation is stretched — the price-to-earnings multiple has climbed over the past month, the P/B ratio is above 13x, and the factor score for short-score rank sits only in the 35th percentile, reflecting the absence of any real short-side pressure to unwind. Citigroup's maintained Neutral at a $248 target is the clearest expression of the fence-sitter view: the numbers are improving, but the stock has run.
The peer group tells a similar story of relative resilience. RH fell nearly 16% on the week, SIG dropped 10%, and FND shed more than 7%. WSM gave up only 1.7% over the same period. That relative strength is consistent with the recent pattern — the past two quarterly prints have both produced positive one-day reactions and follow-through gains of 6–9% over the subsequent five sessions. Insiders, however, have been net sellers. CEO Laura Alber sold approximately $7.7 million of stock in mid-July across multiple transactions, bringing 90-day net selling to roughly $14.9 million. Insider selling at this magnitude ahead of an earnings event rarely signals internal alarm — executive plans are often pre-scheduled — but it is a data point bulls will need to look past.
The August 26 print is ultimately a test of whether Williams-Sonoma can sustain comp sales growth and margin performance at a level that justifies trading above the Street's freshly-upgraded targets — with the stock already having done most of the work before the results land.
See the live data behind this article on ORTEX.
Open WSM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
